+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cytokine Market Report by Cytokine Type, Therapeutic Application, End User, and Region 2024-2032

  • PDF Icon

    Report

  • 150 Pages
  • August 2024
  • Region: Global
  • IMARC Group
  • ID: 5642226
The global cytokine market size reached US$ 89.6 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 163.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2023-2032.

A cytokine refers to a group of proteins, peptides, or glycoproteins released by specific cells to control the growth and activity of the immune system and blood cells. It can regulate immunity, inflammation, and hematopoiesis on account of its high-affinity picomolar concentrations. It is usually injected under the skin or into muscles or veins to help prevent or manage chemotherapy side effects and treat cancer. It also boosts anti-cancer activities by sending signals that make abnormal cells die and normal cells live longer. Presently, it is gaining widespread adoption in cell and gene therapy for the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.

Cytokine Market Trends:

The coronavirus disease (COVID-19) is transmitted via droplets that can induce the excessive production of proinflammatory cytokines and lead to acute respiratory distress syndrome (ARDS) aggravation and tissue damage. As tissue damage can result in multi-organ failure and death, there is a rise in the demand for solutions that target cytokines to manage patients, improve survival rates, and reduce mortality. Apart from this, the increasing prevalence of cancer, in confluence with the escalating demand for minimally invasive surgeries (MIS) that provide less post-operative pain and complications and faster recovery time, is contributing to the market growth.

Moreover, as cytokines act as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases, they are gaining traction in diverse functions, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis. Besides this, the rising cases of atopic dermatitis (AD), a recurrent, chronic, and inflammatory skin disease that processes with severe itchiness, is driving the demand for new cytokines in the pathogenesis of AD and developing improved therapeutic targets.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global cytokine market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cytokine type, therapeutic application and end user.

Breakup by Cytokine Type:

  • Tumor Necrosis Factor-TNF
  • Interleukins-Il
  • Interferons-IFN
  • Epidermal Growth Factor-EGF
  • Others

Breakup by Therapeutic Application:

  • Cancer
  • Asthma and Airway Inflammation
  • Arthritis
  • Others

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Academic and Research Institutes

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.

Key Questions Answered in This Report:

  • How has the global cytokine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cytokine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cytokine type?
  • What is the breakup of the market based on the therapeutic application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cytokine market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cytokine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Cytokine Type
6.1 Tumor Necrosis Factor-TNF
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Interleukins-Il
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Interferons-IFN
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Epidermal Growth Factor-EGF
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Therapeutic Application
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Asthma and Airway Inflammation
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Arthritis
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End User
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Contract Research Organizations
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Academic and Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AbbVie Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Abcam plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Amgen Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.4 Applied Biological Materials Inc. (abm)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Bio-Techne Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 GenScript Biotech Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Randox Laboratories Ltd.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Thermo Fisher Scientific Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 UCB S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
List of Figures
Figure 1: Global: Cytokine Market: Major Drivers and Challenges
Figure 2: Global: Cytokine Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Cytokine Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Cytokine Market: Breakup by Cytokine Type (in %), 2023
Figure 5: Global: Cytokine Market: Breakup by Therapeutic Application (in %), 2023
Figure 6: Global: Cytokine Market: Breakup by End User (in %), 2023
Figure 7: Global: Cytokine Market: Breakup by Region (in %), 2023
Figure 8: Global: Cytokine (Tumor Necrosis Factor-TNF) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Cytokine (Tumor Necrosis Factor-TNF) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Cytokine (Interleukins-Il) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Cytokine (Interleukins-Il) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Cytokine (Interferons-IFN) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Cytokine (Interferons-IFN) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Cytokine (Epidermal Growth Factor-EGF) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Cytokine (Epidermal Growth Factor-EGF) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Cytokine (Other Cytokine Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Cytokine (Other Cytokine Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Cytokine (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Cytokine (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Cytokine (Asthma and Airway Inflammation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Cytokine (Asthma and Airway Inflammation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Cytokine (Arthritis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Cytokine (Arthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Cytokine (Other Therapeutic Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Cytokine (Other Therapeutic Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Cytokine (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Cytokine (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Cytokine (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Cytokine (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: North America: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: United States: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Asia-Pacific: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Asia-Pacific: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: China: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Europe: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Europe: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Germany: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Latin America: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Latin America: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Brazil: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Middle East and Africa: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Middle East and Africa: Cytokine Market: Breakup by Country (in %), 2023
Figure 80: Middle East and Africa: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Cytokine Industry: SWOT Analysis
Figure 82: Global: Cytokine Industry: Value Chain Analysis
Figure 83: Global: Cytokine Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Cytokine Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Cytokine Market Forecast: Breakup by Cytokine Type (in Million US$), 2024-2032
Table 3: Global: Cytokine Market Forecast: Breakup by Therapeutic Application (in Million US$), 2024-2032
Table 4: Global: Cytokine Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Cytokine Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Cytokine Market: Competitive Structure
Table 7: Global: Cytokine Market: Key Players

Companies Mentioned

  • AbbVie Inc.
  • Abcam plc
  • Amgen Inc.
  • Applied Biological Materials Inc. (abm)
  • Bio-Techne Corporation
  • F. Hoffmann-La Roche AG
  • GenScript Biotech Corporation
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • UCB S.A.

Methodology

Loading
LOADING...

Table Information